EUVIMEDEUVIMED entdecken
Crossref

Palliative Care Utilization Among Hospitalized Patients With Hepatocellular Cancer: A Nationwide Study in the Pandemic Era (2019-2021)

Kim Abbegail Tan Aldecoa, Chef Stan L Macaraeg, Marwan S Abougergi, Geetha Krishnamoorthy, Camelia Arsene

American Journal of Hospice and Palliative Medicine® · 2025-06 · 42 (6) · 571-579

DOI: 10.1177/10499091241271371 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Hospice and Palliative Medicine®, online erschienen am 13.08.2024. Verfasst von Kim Abbegail Tan Aldecoa und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Trinity Health Oakland, Pontiac, MI, USA. Hauptthemen laut MEDLINE: Palliative Care, Liver Neoplasms, Carcinoma, Hepatocellular, COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Palliative care addresses a range of needs, from symptom management to providing support to patients with hepatocellular cancer (HCC) and their families throughout the illness. However, research on palliative care in HCC remains limited, particularly during the COVID-19 pandemic. This study investigates the healthcare utilization associated with palliative care referral among patients with HCC.

Methods

This is a retrospective cross-sectional analysis conducted using the National Inpatient Sample (NIS) database from 2019 to 2021 among patients with HCC age ≥18 years.

Results

Among the 35,220 hospitalizations with HCC as the principal diagnosis, 18.7% received inpatient palliative care referrals. Factors associated with increased palliative care referrals included age ≥65 years, Midwest region, Charlson Comorbidity Index (CCI) score ≥3, and end-of-life care, as reflected by discharge resulting in death. No racial or insurance disparities were observed. Palliative care consultations were associated with lower total hospital costs ($20,573 vs $26,035,

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Palliative CareLiver NeoplasmsCarcinoma, HepatocellularCOVID-19Patient Acceptance of Health CareHumansMaleFemaleAgedMiddle AgedCross-Sectional StudiesRetrospective StudiesUnited StatesHospitalizationAdultAged, 80 and overReferral and ConsultationComorbidity

Stichwörter der Autor:innen

HCChealthcare utilizationhepatocellular cancerpalliative carepalliative care utilizationpandemic

Autor:innen und Institutionen

  • Department of Internal Medicine, Trinity Health Oakland, Pontiac, MI, USA.
  • Wayne State University, Detroit, MI, USA.
  • Department of Internal Medicine, University of Connecticut, Farmington, CT, USA.
  • Division of Gastroenterology, Department of Internal Medicine, INOVA Fairfax Medical Campus, Great Falls, VA.
  • Catalyst Medical Consulting, Huntington Valley, PA, USA.

Zitieren

APA

Aldecoa, K. A. T., Macaraeg, C. S. L., Abougergi, M. S., Krishnamoorthy, G., & Arsene, C. (2025). Palliative Care Utilization Among Hospitalized Patients With Hepatocellular Cancer: A Nationwide Study in the Pandemic Era (2019-2021). American Journal of Hospice and Palliative Medicine®, 42(6), 571-579. https://doi.org/10.1177/10499091241271371

Vancouver

Aldecoa KAT, Macaraeg CSL, Abougergi MS, Krishnamoorthy G, Arsene C. Palliative Care Utilization Among Hospitalized Patients With Hepatocellular Cancer: A Nationwide Study in the Pandemic Era (2019-2021). American Journal of Hospice and Palliative Medicine®. 2025;42(6):571-579. doi:10.1177/10499091241271371

BibTeX
@article{Aldecoa2025,
  author = {Aldecoa, Kim Abbegail Tan and Macaraeg, Chef Stan L and Abougergi, Marwan S and Krishnamoorthy, Geetha and Arsene, Camelia},
  title = {Palliative Care Utilization Among Hospitalized Patients With Hepatocellular Cancer: A Nationwide Study in the Pandemic Era (2019-2021)},
  journal = {American Journal of Hospice and Palliative Medicine®},
  year = {2025},
  volume = {42},
  number = {6},
  pages = {571--579},
  doi = {10.1177/10499091241271371}
}
Kostenlos starten →